» Articles » PMID: 36142718

Impact of Environmental Risk Factors on Mitochondrial Dysfunction, Neuroinflammation, Protein Misfolding, and Oxidative Stress in the Etiopathogenesis of Parkinson's Disease

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 Sep 23
PMID 36142718
Authors
Affiliations
Soon will be listed here.
Abstract

As a prevalent progressive neurodegenerative disorder, Parkinson's disease (PD) is characterized by the neuropathological hallmark of the loss of nigrostriatal dopaminergic (DAergic) innervation and the appearance of Lewy bodies with aggregated α-synuclein. Although several familial forms of PD have been reported to be associated with several gene variants, most cases in nature are sporadic, triggered by a complex interplay of genetic and environmental risk factors. Numerous epidemiological studies during the past two decades have shown positive associations between PD and several environmental factors, including exposure to neurotoxic pesticides/herbicides and heavy metals as well as traumatic brain injury. Other environmental factors that have been implicated as potential risk factors for PD include industrial chemicals, wood pulp mills, farming, well-water consumption, and rural residence. In this review, we summarize the environmental toxicology of PD with the focus on the elaboration of chemical toxicity and the underlying pathogenic mechanisms associated with exposure to several neurotoxic chemicals, specifically 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), rotenone, paraquat (PQ), dichloro-diphenyl-trichloroethane (DDT), dieldrin, manganese (Mn), and vanadium (V). Our overview of the current findings from cellular, animal, and human studies of PD provides information for possible intervention strategies aimed at halting the initiation and exacerbation of environmentally linked PD.

Citing Articles

Exceeding the Limits with Nutraceuticals: Looking Towards Parkinson's Disease and Frailty.

Montanari M, Mercuri N, Martella G Int J Mol Sci. 2025; 26(1.

PMID: 39795979 PMC: 11719863. DOI: 10.3390/ijms26010122.


Environmental Risk Factors for Parkinson's Disease: A Critical Review and Policy Implications.

Atterling Brolin K, Schaeffer E, Kuri A, Rumrich I, Schumacher Schuh A, Darweesh S Mov Disord. 2024; 40(2):204-221.

PMID: 39601461 PMC: 11832802. DOI: 10.1002/mds.30067.


Nuclear pore and nucleocytoplasmic transport impairment in oxidative stress-induced neurodegeneration: relevance to molecular mechanisms in Pathogenesis of Parkinson's and other related neurodegenerative diseases.

Riaz Z, Richardson G, Jin H, Zenitsky G, Anantharam V, Kanthasamy A Mol Neurodegener. 2024; 19(1):87.

PMID: 39578912 PMC: 11585115. DOI: 10.1186/s13024-024-00774-0.


Loss of mitochondrial Ca response and CaMKII/ERK activation by LRRK2 mutation correlate with impaired depolarization-induced mitophagy.

Chang E, Liu H, Choi Z, Malki Y, Zhang S, Pang S Cell Commun Signal. 2024; 22(1):485.

PMID: 39390438 PMC: 11465656. DOI: 10.1186/s12964-024-01844-y.


Exosomes in neuron-glia communication: A review on neurodegeneration.

Akbari-Gharalari N, Khodakarimi S, Nezhadshahmohammad F, Karimipour M, Ebrahimi-Kalan A, Wu J Bioimpacts. 2024; 14(5):30153.

PMID: 39296798 PMC: 11406431. DOI: 10.34172/bi.2023.30153.


References
1.
Packer M, Miesel R, Murphy M . Exposure to the parkinsonian neurotoxin 1-methyl-4-phenylpyridinium (MPP+) and nitric oxide simultaneously causes cyclosporin A-sensitive mitochondrial calcium efflux and depolarisation. Biochem Pharmacol. 1996; 51(3):267-73. DOI: 10.1016/0006-2952(95)02165-5. View

2.
Ohishi T, Wang L, Akane H, Shiraki A, Goto K, Ikarashi Y . Reversible aberration of neurogenesis affecting late-stage differentiation in the hippocampal dentate gyrus of rat offspring after maternal exposure to manganese chloride. Reprod Toxicol. 2012; 34(3):408-19. DOI: 10.1016/j.reprotox.2012.04.009. View

3.
Song C, Kanthasamy A, Jin H, Anantharam V, Kanthasamy A . Paraquat induces epigenetic changes by promoting histone acetylation in cell culture models of dopaminergic degeneration. Neurotoxicology. 2011; 32(5):586-95. PMC: 3407036. DOI: 10.1016/j.neuro.2011.05.018. View

4.
Stagg C, Bestmann S, Constantinescu A, Moreno L, Allman C, Mekle R . Relationship between physiological measures of excitability and levels of glutamate and GABA in the human motor cortex. J Physiol. 2011; 589(Pt 23):5845-55. PMC: 3249054. DOI: 10.1113/jphysiol.2011.216978. View

5.
Marxreiter F, Regensburger M, Winkler J . Adult neurogenesis in Parkinson's disease. Cell Mol Life Sci. 2012; 70(3):459-73. PMC: 11113680. DOI: 10.1007/s00018-012-1062-x. View